KP-070

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameKP-070
Drug Alias Nameosteoclastogenesis inhibitor (Kyungpook National University)benzamide derivative (Kyungpook National University)OCLI-070KDS-070KP-070
ClassificationSmall molecules
Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitorsBone resorption inhibitors
TargetsTumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsAlveolar Bone Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKyungpook National University
China Registration ClassN/A

Develop Information

Active CompaniesKyungpook National University
Inactive CompaniesN/A
Active IndicationsAlveolar Bone Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A